Contents

Reviews on Recent Clinical Trials, Volume 10 - Number 1

Graphical Abstract

Graphical Abstracts:

, 10(1): i - iii


DOI: 10.2174/157488711001150521120536




Meet Our Editorial Board Member:

, 10(1): 1

Ludovico Abenavoli


DOI: 10.2174/157488711001150521120703




Editorial

Editorial (Thematic Issue: The Urgent Need to Reform the Present System of Medicines’ Regulation)

, 10(1): 2 - 4

Peter J. Lachmann


DOI: 10.2174/1574887110666150430143930




Access to Medicines and the Safety of the People

, 10(1): 5 - 10

John Harris


DOI: 10.2174/1574887110666150430152618




Genesis of Changes to Legislation and Guidelines that Regulate Clinical Trials

, 10(1): 11 - 14

Brian Davis


DOI: 10.2174/1574887110666150430145105





After Thalidomide – Do We Have the Right Balance Between Public Health and Intellectual Property

, 10(1): 15 - 18

Peter Feldschreiber and Alasdair Breckenridge


DOI: 10.2174/1574887110666150430145520





Realising the Potential of Adaptive Development of Medicines

, 10(1): 19 - 24

Richard W. Barker and Sarah Garner


DOI: 10.2174/1574887110666150430150201





A More Radical Solution

, 10(1): 25 - 27

Peter J. Lachmann


DOI: 10.2174/1574887110666150430151051




Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing

, 10(1): 28 - 43

J. W. Scannell, S. Hinds and R. Evans


DOI: 10.2174/1574887110666150430151751





Empower: Access to Medicine – Working Towards Early Access

, 10(1): 44 - 46

Jennifer Bryant Pearson, James Turgoose and James Hargrave


DOI: 10.2174/1574887110666150430152159





Defining and Managing Expectations for Early Immunotherapy Cancer Trials

, 10(1): 47 - 60

Thomas Kieber-Emmons, Angela Pennisi, Anna Lane, Eric Siegel, Martin Cannon, Behjatolah Monzavi-Karbassi and Issam Makhoul


DOI: 10.2174/1574887110666150227125133





Effect of Flaxseed on Blood Lipid Level in Hyperlipidemic Patients

, 10(1): 61 - 67

Maryam Torkan, Mohammad Hassan Entezari and Mansour Siavash


DOI: 10.2174/1574887110666150121154334





After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?

, 10(1): 68 - 77

Sheila A. Doggrell


DOI: 10.2174/1574887110666150417164603




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science